The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression

OBJECTIVE: To examine the associations between pharmaceutically treated anxiety and depression and incident cardiovascular disease (CVD) among 1‐year prostate cancer survivors. PATIENTS AND METHODS: A registry‐based cohort study design was used to describe the risk of incident CVD in adult 1‐year pr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BJU Int
Asıl Yazarlar: Wollersheim, Barbara M., Boekhout, Annelies H., van der Poel, Henk G., van de Poll‐Franse, Lonneke V., Schoormans, Dounya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2019
Konular:
Urological Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065160/
https://ncbi.nlm.nih.gov/pubmed/31773851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14961
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller